All SEC Filings :: Kintara Therapeutics, Inc. (KTRA)

Filing Type:

Year:

Date	Form	Description	Pages
03/31/21	4	Statement of changes in beneficial ownership of securities	2
03/31/21	4	Statement of changes in beneficial ownership of securities	2
03/30/21	CORRESP	A correspondence can be sent as a document with another submission type or can be sent as a separate submission.	2
03/30/21	UPLOAD	SEC-generated letter Documents TEXT-EXTRACT	1
03/24/21	S-3	Registration statement for specified transactions by certain issuers Documents EX-4.22 EX-4.23 EX-5.1 EX-5.2 EX-23.1 EX-23.2	158
02/12/21	8-K	Current report filing Documents EX-99.1	7
02/12/21	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-31.1 EX-31.2 EX-32.1 EX-32.2	54
02/08/21	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions	8
01/29/21	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions	4
01/04/21	4	Statement of changes in beneficial ownership of securities	2